+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Savara Pharmaceuticals - logo

Savara Pharmaceuticals is a company that develops products for rare and life threatening respiratory diseases. Savara is a US based company with an affiliate company in Copenhagen, Denmark established in 2008. They have 3 main products: Molgradex, AeroVanc & Aironite. Molgradex is an inhalation medication used for the treatment of PAP. Aerovanc is another drug used to combat MRSA (Methicillin-resistant Staphylococcus aureus). Aironite is inhaled through nebulizer to treat heart failure patients with preserved ejection fraction (HFpEF).

Autoimmune pulmonary alveolar proteinosis (aPAP) - Pipeline Insight, 2024 - Product Thumbnail Image

Autoimmune pulmonary alveolar proteinosis (aPAP) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Targeted Drug Delivery System Market by Product, Application - Global Forecast 2025-2030 - Product Thumbnail Image

Targeted Drug Delivery System Market by Product, Application - Global Forecast 2025-2030

  • Report
  • October 2024
  • 186 Pages
  • Global
From
Collaboration Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2019-2024

  • Report
  • September 2024
  • 1150 Pages
  • Global
From
Stroke Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Stroke Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 580 Pages
  • Global
From
Peptide Antibiotics Market by Type, Disease, Route of Administration, Distribution Channel - Global Forecast 2025-2030 - Product Thumbnail Image

Peptide Antibiotics Market by Type, Disease, Route of Administration, Distribution Channel - Global Forecast 2025-2030

  • Report
  • October 2024
  • 189 Pages
  • Global
From
Inhaled Antibiotics Global Market Report 2024 - Product Thumbnail Image

Inhaled Antibiotics Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
MRSA Drugs - Global Strategic Business Report - Product Thumbnail Image

MRSA Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 183 Pages
  • Global
From
Rare Kidney Diseases Global Market Report 2024 - Product Thumbnail Image

Rare Kidney Diseases Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Peptide Antibiotics Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Peptide Antibiotics Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • November 2023
  • 115 Pages
  • Global
From
Nontuberculous Mycobacterial (NTM) Infections - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Nontuberculous Mycobacterial (NTM) Infections - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 101 Pages
  • Global
From
Stroke - Pipeline Review, H2 2020 - Product Thumbnail Image

Stroke - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 773 Pages
  • Global
From
Comprehensive Report on Savara Inc, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on Savara Inc, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
Savara Inc (SVRA) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Savara Inc (SVRA) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • October 2024
  • 41 Pages
From
  • 13 Results (Page 1 of 1)
Loading Indicator